Business
Andrew Paris, MBA, Chris M. Kozma, PhD, Wing Chow, PharmD, MPH, Anisha M. Patel, MS, Samir H. Mody, PharmD, MBA, Myoung S. Kim, PhD, MBA
Can Substituting Generic Drugs with Brand-Name Agents for Acute Pain Postsurgery Help to Deliver Cost-Effective, Quality Care?
Modeling the Future Economic Impact of Biosimilars’ Entry into the US Market
Jonah Broulette, ASA, MAAA, Holly Yu, MSPH, Kosuke Iwasaki, FIAJ, MAAA, Reiko Sato, PhD, Bruce S. Pyenson, FSA, MAAA
CAP Is a Burden for All Ages—Prevention Strategies Are Key
Innovation in Patient Engagement and Management Is Critically Needed to Change Current Trends in Type 2 Diabetes
Much More than Biomarkers: Sociodemographic Variables in Personalized Medicine
Marie-Hélène Lafeuille, MA, Jonathan Gravel, MSc, Amanda Grittner, MA, Patrick Lefebvre, MA, Lorie A. Ellis, PhD, Scott McKenzie, MD
New Oncology Care Delivery Payment Models to Enhance Care Efficiency
Cost and Effectiveness of Therapies for Advanced Kidney Cancer: The Need for Economic and Clinical Analyses